Indications
Therapeutic Asset Ratings
6,305 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Benmelstobart
Cancer
Jinming Yu
P1/2
CC
(45)
Benmelstobart
Melanoma
Beijing Tide Pharmaceutical Co., Ltd
P1/2
CC
(45)
Bet Bromodomain Inhibitor Zen-3694
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P1/2
CC
(45)
bg1805
Acute Myeloid Leukemia
Guangzhou Bio-gene Technology Co., Ltd
P1/2
CC
(45)
bh-30643
Non-Small Cell Lung Carcinoma
BlossomHill Therapeutics
P1/2
CC
(45)
bi-1808
T-Cell Non-Hodgkin Lymphoma
BioInvent International AB
P1/2
CC
(45)
Bicalutamide
Metastatic Neoplasm
Icahn School of Medicine at Mount Sinai
P1/2
CC
(45)
Bifidobacterium Bifidum
Hepatocellular Carcinoma
Sun Yat-sen University
P1/2
CC
(45)
Biological Ntla-3001
Lung Disorder
Intellia Therapeutics
P1/2
CC
(45)
Blinatumomab
High Grade B-Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(45)
Blinatumomab
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer Center
P1/2
CC
(45)
bmd006
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(45)
Bms-936558-01
Head And Neck Squamous Cell Carcinoma
Bristol-Myers Squibb
P1/2
CC
(45)
Bms 986253
Prostate Adenocarcinoma
Mark Stein
P1/2
CC
(45)
BN104
Acute Myeloid Leukemia
Chen Suning
P1/2
CC
(45)
bnt324
Lung Cancer
BioNTech SE
P1/2
CC
(45)
bnt327
Lung Cancer
BioNTech SE
P1/2
CC
(45)
Bortezomib
Li-Fraumeni Syndrome
Masonic Cancer Center, University of Minnesota
P1/2
CC
(45)
Bpi-1178
Hormone Receptor-Positive Breast Cancer
Beta Pharma (Suzhou) Co., Ltd.
P1/2
CC
(45)
br790
Cancer
Shanghai Gopherwood Biotech Co., Ltd.
P1/2
CC
(45)
Brivestobart
Non-Small Cell Lung Carcinoma
Guangzhou Gloria Biosciences Co., Ltd.
P1/2
CC
(45)
Brl-101
Beta Thalassemia
Bioray Laboratories
P1/2
CC
(45)
bs006
Neoplasm
Binhui Biopharmaceutical Co., Ltd.
P1/2
CC
(45)
Bsb-1001
Myelodysplastic Syndrome
BlueSphere Bio, Inc
P1/2
CC
(45)
bt02
Plasma Cell Myeloma
Biotroy Therapeutics
P1/2
CC
(45)
Showing 3051 to 3075 of 6,305 assets
Previous
Page 123 of 253
Next